ArticleTherapeutic advances in drug safety2022

Could chlorophyllins improve the safety profile of beta-d-N4-hydroxycytidine versus N-hydroxycytidine, the active ingredient of the SARS-CoV-2 antiviral molnupiravir?

Nicole F Clark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.